Back
Structure Therapeutics Vs. Smith-Midland Industry Stock Comparison
Sell
34
GPCR
Structure Therapeutics
Last Price:
38.10
Seasonality Move:
-36.06%
Buy
63
SMID
Smith-Midland
Last Price:
37.29
Seasonality Move:
24.72%
Sell
34
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy, Sell or Hold?
- The current Structure Therapeutics [GPCR] share price is $38.03. The Score for GPCR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- GPCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Smith-Midland (SMID)
is a Buy
Is Smith-Midland a Buy, Sell or Hold?
- The current Smith-Midland [SMID] share price is $37.36. The Score for SMID is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- SMID is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GPCR Stock Price Chart
What is Structure Therapeutics's stock price today?
-
The Structure Therapeutics share price today is $38.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight buying pressure.
SMID Stock Price Chart
What is Smith-Midland's stock price today?
-
The Smith-Midland share price today is $37.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMID is experiencing slight buying pressure.
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 45.31 | Sell |
| Chaikin Money Flow: | 23482 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.47 - 40.47) | Sell |
| Bollinger Bands (100): | (36.36 - 41.98) | Sell |
SMID Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 66.01 | Buy |
| Chaikin Money Flow: | 11848 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.57 - 35.23) | Buy |
| Bollinger Bands (100): | (29.53 - 35.07) | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.24 | Sell |
| 20-day SMA: | 38.57 | Sell |
| 50-day SMA: | 39.47 | Sell |
| 200-day SMA: | 40.23 | Sell |
| 8-day EMA: | 38.78 | Sell |
| 20-day EMA: | 39.03 | Sell |
| 50-day EMA: | 39.28 | Sell |
| 200-day EMA: | 39.68 | Sell |
SMID Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.3 | Buy |
| 20-day SMA: | 33.97 | Buy |
| 50-day SMA: | 33.77 | Buy |
| 200-day SMA: | 35.69 | Buy |
| 8-day EMA: | 35.56 | Buy |
| 20-day EMA: | 34.5 | Buy |
| 50-day EMA: | 33.79 | Buy |
| 200-day EMA: | 33.19 | Buy |
Structure Therapeutics Earnings Growth & GPCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.
Smith-Midland Earnings Growth & SMID Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Structure Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Smith-Midland Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||